Paeds Vivas · haematology-oncology-and-transfusion
Aplastic anaemia and bone-marrow failure: Viva
Branching clinical structured oral on aplastic anaemia and inherited bone marrow failure in children, covering the Camitta severity criteria, the immune-mediated pathophysiology, the diepoxybutane test for Fanconi anaemia, the treatment fork of transplant versus immunosuppression, the horse versus rabbit antithymocyte globulin choice, and the eltrombopag and the RACE trial, appraising the Camitta, Frickhofen, Scheinberg, and Peffault de Latour evidence.
On this page
Study tools
Target exams
This is a presentation of severe aplastic anaemia in a nine-year-old boy, meeting the Camitta criteria. The structured oral runs from the severity grading through the pathophysiology, the exclusion of the inherited syndromes, the treatment fork, and the trial evidence, and it ends with the long term counselling. [1]
Opening: grade the severity
Examiner. This boy has pancytopenia and a hypocellular marrow. How do you grade the severity, and what does the grade mean for the treatment? [1]
Candidate. The boy meets the Camitta criteria for severe aplastic anaemia, which is a marrow cellularity under 25 percent together with at least two of three peripheral blood thresholds. He has a cellularity of 15 percent, which meets the marrow criterion, and he meets all three blood thresholds: the neutrophils of 0.3 times ten to the nine per litre are under 0.5, the platelets of 12 times ten to the nine per litre are under 20, and the reticulocytes of 10 times ten to the nine per litre are under 60. The grade is severe, and it is close to very severe, which is the neutrophils under 0.2 times ten to the nine per litre. The grade matters because the severe and the very severe disease are treated aggressively with the transplant or the immunosuppression, while the non-severe disease is often managed supportively. [1]
References5ShowHide
- [1]Camitta BM, Thomas ED, Nathan DG, et al Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood, 1976.PMID 779871
- [3]Frickhofen N, Kaltwasser JP, Schrezenmeier H, et al Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med, 1991.PMID 2017225
- [4]Scheinberg P, Nunez O, Weinstein B, et al Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med, 2011.PMID 21812672
- [7]Peffault de Latour R, Kulasekararaj A, Iacobelli S, et al Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia. N Engl J Med, 2022.PMID 34986284
- [9]Auerbach AD Fanconi anemia and its diagnosis. Mutat Res, 2009.PMID 19622403